参考文献

1.Saag MS，Graybill RJ，Larsen RA，et al.Practice guidelines for the management of cryptococcal disease.Infectious Diseases Society of America.Clin Infect Dis，2000，30（4）:710-718.

2.Shoham S，Cover C，Donegan N，et al.Cryptococcus neoformans meningitis at 2 hospitals in Washington，D.C.:adherence of health care providers to published practice guidelines for the management of cryptococcal disease.Clin Infect Dis，2005，40（3）:477-479.

3.Perfect JR，Dismukes WE，Dromer F，et al.Clinical p ractice guidelines for the management of cryptococcal disease:2010 update by the infectious diseases society of America.Clin Infect Dis，2010，50（3）:291-322.(https://www.daowen.com)

4.Shelburne SA，Visnegarwala F，Darcourt J，et al.Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy.AIDS，2005，19:399-406.

5.Singh N，Lortholary 0，Alexander BD，et al.An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients.Clin Infect Dis，2005，40:1756-1761.

6.Ecevit IZ，Clancy CJ，Schmalfuss IM，et al.The poor prognosis of central nervous system cryptococcosis among nonimmunosuppressed patients:a call for better disease recognition and evaluation of adjuncts to antifungal therapy.Clin Infect Dis，2006，42:1443-1447.